Midatech Andalucia, a Spanish subsidiary of the UK's Midatech Group, a world leader in the production and application of synthetically produced biological nanoparticles, has signed an exclusive worldwide license agreement with the Spain's Universidad Complutense de Madrid and the Materials Science Institute of Seville, which is a shared center of the Consejo Superior de Investigaciones Cientificas and the University of Sevilla. The license allows Midatech Andalucia to extend its world leadership in the field of localized heating of mammalian, bacterial and plant cells. This extends Midatech's priority applications dating back to 2000 and 2003 respectively (WO 02/32404, WO 04/108165) to now include the important discovery of magnetic behavior in noble metal nanoparticles.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze